Document is current
Any future updates will be listed below
-
Authors
Irodi, Anushka https://orcid.org/0009-0007-7307-6750
Zhu, Zhuoting
Grzybowski, Andrzej https://orcid.org/0000-0002-3724-2391
Wu, Yilan https://orcid.org/0000-0003-0493-9958
Cheung, Carol Y. https://orcid.org/0000-0002-9672-1819
Li, Huating
Tan, Gavin https://orcid.org/0000-0001-5383-7136
Wong, Tien Yin https://orcid.org/0000-0002-8448-1264
- License Information
-
More Information
Article History
Received: 30 October 2024
Revised: 6 January 2025
Accepted: 22 January 2025
First Online: 5 February 2025
Competing interests
: TYW is a consultant for Abbvie Pte Ltd, Aldropika Therapeutics, Bayer, Boehringer-Ingelheim, Carl Zeiss, Genentech, Iveric Bio, Novartis, Opthea Limited, Plano, Quaerite Biopharm Research Ltd, Roche, Sanofi, Shanghai Henlius. He is an inventor, holds patents and is a co-founder of start-up companies EyRiS and Visre, which have interests in, and develop digital solutions for eye diseases. CYC and AG are members of the Eye editorial board.
